The Future of Blood Cancer Treatments

The Future of Blood Cancer Treatments

At Swedish, our team of renowned specialists is breaking new ground in novel immunotherapies and stem cell transplantation. Our work is helping our own patients and patients around the world live longer and better lives after a leukemia, lymphoma, or multiple myeloma diagnosis.

Join us for a virtual event to learn how Bill Bensinger, MD and Krish Patel, MD are shaping the future of cancer care through their work and research at the Swedish Cancer Institute Center for Blood Disorders and Stem Cell Transplantation.

Wednesday, October 27 | 12:00 - 1:00 p.m. (PT) I Online Event

Register Now

Not available during these times? You can register now and receive a recording after the event. This webinar is free and open to the public. Please share with your family, friends and colleagues. Questions: Please email [email protected] or call 206-386-2738

Bensinger

William Bensinger, M.D., is a medical oncologist at the Swedish Cancer Institute Center for Blood Disorders and Stem Cell Transplantation. He specializes in caring for patients with multiple myeloma. Through his research, he investigates novel treatment options like immunotherapies that can offer hope to patients with advanced cancer.

 

 

 

Patel

Krish Patel, MD is the Director of the Lymphoma Program at the Swedish Cancer Institute Center for Blood Disorders and Stem Cell Transplantation. In addition to his clinical work as a stem cell transplant physician, Dr. Patel is interested in the early stage development of novel targeted agents, immunotherapies, and cellular therapies (including CAR T-cell therapy) to advance care for patients with lymphoid malignancies.